August 09, 2022
Video
Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.
August 01, 2022
Article
At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.
July 30, 2022
After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.
July 14, 2020
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
July 13, 2020
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
July 12, 2020
Why men who have sex with men face social hurdles in seeking PrEP and preventive education.
How regional-based data and advancing preventive options could bolster individual HIV-risk care access.
July 10, 2020
Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.
A study looking at PrEP population obstacles shows men who have sex with men are more likely to not seek out information nor access to prophylaxis.
Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.
Infectious Disease Update: This Week's Top 5 Stories
Experimental HIV Vaccine Elicits Broadly Neutralizing Antibodies
Considering Criteria for Admission for Skin and Soft Tissue Infections
Utilizing a Novel Modality to Treat Pulmonary Fungal Infections in Lung Transplant Patients
